PF-06763809
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-06763809, covering 2020-06-25 to 2020-06-25. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis [Phase 1]